First U.S. Patient Randomized in a Phase 2 Urticaria Trial

New Orleans, LA –

Huge congratulations to Dr. Deirdre Hooper and her incredible team for randomizing the first patient in a Phase 2 urticaria trial!

We’re proud to celebrate this exciting milestone with Dr. Hooper – with more than 60 clinical trials completed as a Principal Investigator and Sub Investigator in partnership with DelRicht Research, she and her practice partner Dr. Sarah Jackson at Audubon Dermatology have consistently demonstrated what it means to be trusted investigators and true leaders in dermatology research.

Thank you, Dr. Hooper, for your continued dedication to advancing care and moving medicine forward!